Lung Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Lung Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) [Phase 3]
A Phase 3 clinical trial (Chemo-IO ACCIO) is evaluating adding an immunotherapy agent to standard chemotherapy for non-small cell lung cance…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial evaluates stereotactic body radiation therapy with or without nivolumab for patients with Stage I-IIA or recurre…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations [Phase 1, Phase 2]
Phase 1/2 trial of TER-2013 in solid tumors harboring AKT/PI3K/PTEN alterations is currently recruiting to assess safety and preliminary eff…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer [Phase 1]
Phase I clinical trial evaluating C-CAR031, a GPC3-targeted CAR T-cell therapy, in participants with advanced or metastatic squamous cell lu…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: JMT106 Injection in the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating JMT106 injection for advanced solid tumors, including lung squamous cell carcinoma and hepatocellular carcinoma, is…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer [Phase 2]
Phase II clinical trial evaluating low-dose radiation with SBRT plus Sintilimab and chemotherapy versus Sintilimab and chemotherapy in local…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma
This clinical trial update discusses predictive biomarkers for response to PD-1 inhibitors in squamous cell carcinomas, spanning esophageal,…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT [Phase 2]
A Phase 2 clinical trial is evaluating whole-body HER3 quantification using radiolabeled patritumab deruxtecan (HER3-DXd) PET/CT in non-smal…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: BAI-BACE for Advanced Lung Squamous Cell Carcinoma [NA]
Clinical trial update for BAI-BACE in advanced lung squamous cell carcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma
This study investigates mechanisms behind differing efficacy of neoadjuvant chemoimmunotherapy in lung squamous cell carcinoma, focusing on …
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial evaluating neoadjuvant EGFR-targeted therapy in patients with resectable EGFR-mutated lung squamous cell ca…
-
CLINICAL_TRIALS research · 2018-04-03Clinical Trial Update: Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial is evaluating afatinib in combination with chemotherapy for esophageal squamous cell carcinoma or lung squamous cell carcino…
-
CLINICAL_TRIALS research · 2015-12-22Clinical Trial Update: Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating Boanmycin hydrochloride in combination with docetaxel for patients with lung squamous cell carcinoma; stat…
-
CLINICAL_TRIALS research · 2015-12-15Clinical Trial Update: Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating concurrent nab-paclitaxel and carboplatin with thoracic radiotherapy in squamous cell non-small cel…